Verastem, Inc. (LON:0LOV)
London · Delayed Price · Currency is GBP · Price in USD 7.89
-1.93 (-19.67%)
At close: Nov 4, 2025
Verastem Employees
Verastem had 78 employees as of December 31, 2024. The number of employees increased by 5 or 6.85% compared to the previous year.
Employees
78
Change (1Y)
5
Growth (1Y)
6.85%
Revenue / Employee
127.60K GBP
Profits / Employee
-2.30M GBP
Market Cap
373.15M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 78 | 5 | 6.85% |
| Dec 31, 2023 | 73 | 16 | 28.07% |
| Dec 31, 2022 | 57 | 9 | 18.75% |
| Dec 31, 2021 | 48 | 0 | - |
| Dec 31, 2020 | 48 | -87 | -64.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Spire Healthcare Group | 15,703 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
Verastem News
- 8 days ago - 3 Cancer-Focused Stocks Showing Strong Pipeline Progress - Nasdaq
- 13 days ago - Verastem (VSTM) Reveals Promising Early Results from VS-7375 Clinical Trial - GuruFocus
- 13 days ago - Verastem Oncology Announces Encouraging Preliminary Data from Ongoing Phase 1/2a Dose Escalation Trial of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, in Patients with KRAS G12D Mutant Solid Tumors - Business Wire
- 13 days ago - Verastem (VSTM) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? - Nasdaq
- 13 days ago - Verastem Oncology to Report Third Quarter 2025 Financial Results on November 4, 2025 - Business Wire
- 16 days ago - Verastem (VSTM) Remains Strong Despite Recent Drop in Share Price - GuruFocus
- 16 days ago - Verastem (VSTM) Announces Promising Results from KRAS G12D Inhibitor Study - GuruFocus
- 16 days ago - Are You Looking for a Top Momentum Pick? Why Verastem (VSTM) is a Great Choice - Nasdaq